AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Mosab Nouraldein Mohammed Hamad, Head of Parasitology Department, College of Health and Allied Sciences, St. Joseph University in Tanzania, Dar Es Salaam, Tanzania.
Citation: Tarig M A Mohamed, Ghanem M Mahjaf, Mosab N Mohammed Hamad*. (2022). E Evaluate the adequacy of Warfarin Treatment Among Patients who were on long term Anticoagulation Therapy in Ahmed Gasim Cardiac Center, Khartoum- Sudan. Cardiology Research and Reports. 4(6); DOI: 10.31579/2692-9759/066
Copyright: © 2022 Mosab Nouraldein Mohammed Hamad,This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 06 June 2022 | Accepted: 12 June 2022 | Published: 17 July 2022
Keywords: warfarin; adequacy; anticoagulation; therapy; khartoum, Sudan.
Warfarin therapy for the prevention and treatment of thromboembolic diseases is safe and effective when it is maintained with a narrow therapeutic window measured by the international normalization ratio (I.N.R).Failure to provide adequate anticoagulation consistently predict thromboembolic events( eg stroke and pulmonary embolism), while excessively anticoagulated patients were at risk of bleeding. The management of therapy within this narrow window is complicated by numerous factors including drug interaction, comorbid acute, and chronic diseases, diet, and a variety of patient responses to warfarin therapy. The study was conducted in Ahmed Gasim cardiac center outpatient anticoagulation clinic. The study was carried out in the period from January to December 2012. Patients admitted or attending Ahmed Gasim cardiac center for follow-up of their long-term anticoagulation therapy. From all these results during the follow-up period. We found the percentage of those who were adequately controlled at the normal therapeutic I.N.R range was (54.7%) versus (45.3%) for uncontrolled patients. Of those who were controlled, we found(133) patients (60.7%) of them were fully educated about the interaction between diet and medications, while (31) patients (38.3%) were not receiving education about such interaction. On the other hand, those who were not controlled according to their therapeutic I.N.R (50) patients (61.7%) were not having educated and (86) patients (39.7%) were educated and have knowledge about dietary and drug interaction. P-value (0.01).The study of the adequacy of anticoagulation shows suboptimal control in (45.3%) of patients on patients attending INR clinics, however, the adequacy varies with age group with elderly patients poorly anticoagulated. Finally, the overall research conclude that the adequacy of anticoagulation was suboptimal with (54.6%) adequately controlled versus (45.3%) uncontrolled. In conclusion, the INR range of anticoagulation at the referral clinic mostly falls in the “under anticoagulated range”. Areas to be considered are patient attendance, staffing and at the same time increasing the efficiency of services. Improvement should be directed not only toward attaining better patient attendance at the clinic but also to educate patients on the importance of adequate control.
Warfarin therapy for the prevention and treatment of thromboembolic diseases is safe and effective when it is maintained with a narrow therapeutic window measured by the international normalization ratio (I.N.R).Failure to provide adequate anticoagulation consistently predict thromboembolic events( eg stroke and pulmonary embolism), while excessively anticoagulated patients were at risk of bleeding. The management of therapy within this narrow window is complicated by numerous factors including drug interaction, comorbid acute, and chronic diseases, diet, and variety of patient responses to warfarin therapy [1]. The integrity of the circulation is maintained by blood flowing through intact vessels lined by endothelial cells. Injury to the vessel wall exposes collagen and together with tissue injury sets in motion a series of events leading to homeostasis [2]. Hemostasis is a complex process depending on interactions between the vessel wall, platelets, and coagulation, and fibrinolytic mechanisms[2].
Platelet adhesion:- When the vessel wall is damaged, the escaping platelets come into contact with and adhere to collagen and the von Will brand factor that is bound below the endothelium. This is mediated through glycoprotein Ib (GPIb) Glycoprotein IIb–IIIa is then exposed, forming a second binding site for VWF. Within seconds of adhesion to the vessel wall platelets begin to change shape, from a disc to a sphere, spread along the subendothelium, and release the contents of their cytoplasmic granules, i.e. the dense bodies (containing ADP and serotonin) and -granules containing platelet-derived growth factor, thrombomodulin, fibrinogen, VWF, fibronectin, thrombospondin, and other factors) [2]. Platelet release:- The release of ADP leads to a conformational change in the fibrinogen receptor, the glycoprotein IIb–IIIa complex (GPIIb–IIIa), on the surfaces of adherent platelets allowing it to bind to fibrinogen. Platelet aggregation:- As fibrinogen is a dimer it can form a direct bridge between platelets and so binds platelets into activated aggregates (platelet aggregation) and further platelet release of ADP occurs. A self-perpetuating cycle of events is set up leading to the formation of a platelet plug at the site of the injury. Coagulation:- After platelet aggregation and release of ADP, the exposed platelet membrane phospholipids are available for the assembly of coagulation factor enzyme complexes (tenase and prothrombinase); this platelet phospholipid activity has been called platelet factor 3[2,3].
There is both parenteral and oral anticoagulant currently the parenteral anticoagulant include heparin and low molecular weight heparin and the oral anticoagulant vitamin K antagonist warfarin. For long-term chronic management, oral anticoagulation is preferred over the intravenous or subcutaneous routes due to patient convenience and cost. Warfarin has been in clinical use for over six decades and it is still one of the most widely used oral anticoagulant agents. Warfarin and other vitamin K antagonists (VKAs, eg, acenocoumarol, phenprocoumon, fluindione) are the standard oral anticoagulants used in a variety of clinical settings[4].
Commercially-available warfarin is a racemic mixture of S and R enantiomers. The more potent S form of the drug is metabolized primarily by the CYP2C9 hepatic microsomal enzyme system. This enzyme system is inducible by many drugs and has several genetic variants, both of which may profoundly alter warfarin in vivo activity. Warfarin is strongly protein-bound, primarily to albumin; only the non-protein-bound fraction is biologically active. Accordingly, any agent that is also bound to albumin may displace warfarin from its albumin binding sites and increase its biological activity. Warfarin is water-soluble and completely absorbed after oral administration. The majority of the drug is absorbed in the proximal small bowel, although successful use of the sublingual route has been described in two patients. Excretion is via the urine, primarily as drug metabolites. The long half-life of 20 - 60 hours. The mean half-life is approximately 40 hours. The duration of effect is 2 - 5 days. The maximum effect of a dose occurs up to 48 hours after administration and the effect lasts for the next 5 days. Steady State requires 5-7 days [4].
The anticoagulant effect of warfarin is mediated through inhibition of the vitamin K-dependent gamma-carboxylation of coagulation factors II, VII, IX, and X [4]. This effect of warfarin results in the synthesis of immunologically detectable but biologically inactive forms of these coagulation proteins. Warfarin also inhibits the vitamin K-dependent gamma-carboxylation of proteins C and S, which have anticoagulant properties through their inhibition of activated factors VIII and V [4]. Because of these competing effects, vitamin K antagonists such as warfarin create a biochemical paradox by producing an anticoagulant effect due to the inhibition of procoagulants (factors II, VII, IX, and X) and a potentially thrombogenic effect by impairing the synthesis of naturally occurring inhibitors of coagulation (proteins C and S). The ultimate anticoagulant effect of warfarin is delayed until the normal clotting factors, especially prothrombin, are cleared from the circulation. The peak effect does not occur until 36 to 72 hours after drug administration, especially because the plasma half-life of factor II (prothrombin) is approximately 3 days During the first few days of warfarin therapy, prolongation of the prothrombin time mainly reflects its action on the extrinsic coagulation pathway, through the depression of factor VII, which has a half-life of four to six hours. The other vitamin K-dependent factors within the common and intrinsic coagulation pathways (i.e., factors II, IX, and X) remain relatively unchanged during the first few days. Accordingly, the patient is not fully anticoagulated with warfarin until these other components are also reduced[5].
Equilibrium levels of factors II (prothrombin), IX, and X, approximately 10 to 35 percent of normal at therapeutic INR levels (11), are reached about one week after the initiation of therapy. For this reason, parenteral anticoagulants and warfarin should OVERLAP by four to five days when warfarin is initiated in patients with the acute thrombotic disease (eg, venous thromboembolism, heparin-induced thrombocytopenia) [5].
Many medicines can interact with anticoagulants. Some medicines can increase the effect of anticoagulants, thus increasing the chances of bleeding. Some medications can decrease the effect of anticoagulants, thus increasing the chances of blood clots[6].
Polymorphisms in the genes for the following two enzymes have been associated with altered sensitivity to warfarin [7].
Hepatic cytochrome P-450 2C9 (CYP2C9), is involved in the metabolic clearance of warfarin. Vitamin K epoxide reeducates complex 1 (VKORC1), which recycles vitamin K and is required for gamma-carboxylation of vitamin K-dependent coagulation factors. Cytochrome P-450 2C9 -A well-studied cause for individuality in patient responses to warfarin is the presence of genetic variation (polymorphisms) in the hepatic cytochrome P-450 2C9 (CYP2C9) isoenzyme, which inactivates both warfarin and acenocoumarol[8,9].
Study design:
Retrospective and prospective observational hospital-based study.
Study area and time:
The study was conducted in Ahmed Gasim cardiac center outpatient anticoagulation clinic. The study was carried out in the period from January to December 2012.
Study population:
Patients admitted or attending Ahmed Gasim cardiac center for follow-up of their long-term anticoagulation therapy. Ahmed Gasim center is the cardiac center which is a treachery hospital in North Khartoum for surgical and medical treatment of cardiac problems.
Study sample:
A sample size of 300 patients was studied.
Inclusion criteria:
Patients who were on long-term anticoagulant therapy for more than three months.
Exclusion criteria:
Interrupted or stopped for any reason oral anticoagulant medication. Patients who were treated with medication other than oral anticoagulant therapy e.g., antiplatelet tablet, or those on heparin treatment alone. Period of anticoagulation less than 3 months duration.
Data collection:
Personal and demographic data from all patients are collected using a direct questionnaire (attached)including the indication for anticoagulation, the frequency of follow up
Main outcome measure:
The percentage of international normalized ratio (I.N.R) tested below, within, and above the therapeutic range were determined. The patient was classified as adequately anticoagulated if the measured INR was within the therapeutic range for the indicative cause of anticoagulation. On the other hand, the patients were regarded as over anticoagulated or under-coagulated if the measured result of INR lagged by (0.5) above and below the therapeutic range respectively. In addition, the quality of education given to the patient at the start of using anticoagulant therapy was assessed, together with the frequency of bleeding and other complication encountered.
Data processing:
Collected data from the forms entered into a computer at the end of the study and analyzed using the software program SPSS v16. The means, standard deviations, and frequencies were defined. The correlation between the patient's anticoagulation measures to the targeting I.N.R is tested using a chi-square test. The difference between means is tested using an independent t-test. P-value >0.05 is said to be significant.
Ethical consideration &clearance:
Verbal consent was taken from all patients after explanation of the study, Ethical clearance from the authorities is taken before the start of the study.
During the study period (300) patients were enrolled, among them (193) were females (64.33 %) and (107) were males (35.67%). The majority of patients (131) ( 43.7%) were between the age of (21-40) years followed by (110) patients (37.6%) aged between (41-60) years. There were (29 ) patients (9.7%) between (61-80 ) years, (27) patients (9% ) at age less than 20 years and (3) patients (1%) < 80>P-value of (0.75). For patients who develop minor bleeding (33)patients(75%)were not educated (11)patients (25%) were educated P-value (0.74). We found only one patient who develop a thromboembolic event (stroke) who was anticoagulated for prosthetic valve and was not fully educated (Table1). According to age group, all elderly patients above 80 years (3) patients were uncontrolled. In patients between (61-8o) age group (20) patients (69%) were uncontrolled versus (9) patients (31%) who were controlled. On the other hand, for patients aged (41-60), most of the patients (69) patients (62.7%) were adequately controlled versus (41) patients (37.3%) uncontrolled. In patients in (the 21-40) age group which pick the majority of patients studied we found (72) patients (55%) controlled versus (59) patients (45%) uncontrolled. In patients in (1-20 )age group we found (14) patients (51.9%) controlled versus (13) patients (48.1%) uncontrolled .P value (0.001) (Table2). In this study, 300 patients were followed for three consecutive follow-ups, during each follow up their results of I.N.R were recorded. During the first visit, we found (151) patients (50.3%)within the normal therapeutic I.N.R, while( 92) patients (30.7%) were having lower than normal therapeutic I.N.R. and (57) patients (19%) having higher than therapeutic I.N.R. In the second visit there were (169) patients(56.3%) have resulted within normal therapeutic I.N.R, while (81) patients(27%) were having lower than normal therapeutic I.N.R and (50) patients (16.7%) having higher than normal therapeutic I.N.R . In the third visit there were (176) patients(58.7%) have resulted within the normal I.N.R, while (77) patients(25.7%) were having lower than normal therapeutic I.N.R and (47) patients(15.7%) having higher than normal therapeutic I.N.R (15.7%). Regarding the clinical indication of anticoagulation we found that in patients with mechanical valve replacement, the percentage of controlled I.N.R is higher (65.5%) versus those uncontrolled (34.5%). On the other hand, the percentage of uncontrolled patients was high among those anticoagulated because of cardiomyopathy (62.8%) while only (28.3%) were adequately controlled .also in patients with pulmonary embolism (71.4%) were uncontrolled versus (28.6%) of controlled one. In patients with D.V.T, there were (57.1%) uncontrolled versus (42.9%) controlled. The uncontrolled patients predominate over-controlled ones in patients with atrial fibrillation (56.2%) versus (28.3%). From all these results during the follow-up period. We found the percentage of those who were adequately controlled at the normal therapeutic I.N.R range was (54.7%) versus (45.3%) for uncontrolled patients.Of those who were controlled, we found(133) patients (60.7%) of them were fully educated about the interaction between diet and medications, while (31) patients (38.3%) were not receiving education about such interaction. On the other hand, those who were not controlled according to their therapeutic I.N.R (50) patients (61.7%) were not having educated and (86) patients (39.7%) were educated and have knowledge about dietary and drug interaction. P-value (0.01)(Table3). Regarding the effect of the adequacy of INR control on patients who develop complications during the period of follow up, we found that the percentage of complications of major bleeding was increased in patients with inadequate INR control (55%) versus (45%) with adequately controlled I.N.R. P-value (0.36) (Table4). Also the percentage of minor bleeding was increased in patients with inadequate I.N.R (56.8%) versus (43.2%) with adequately controlled I.N.R P-value (0.98). On the other hand, the only one patient who developed a thromboembolic event during the follow-up was found an inadequate INR control P-value (0.27).(Table5).
anticoagulation control during initiation and maintenance of warfarin treatment is generally unsatisfactory. Compared to a study conducted in 2008 in Canada about the quality of anticoagulation in long term care, where (107) patients who were receiving warfarin (72%) of them were female with a mean age of( 65—90 years) (89), Our study also shows female predominance (64.3%) but with younger mean age (mean range 20—40 years). The main indications of anticoagulation were stroke prophylaxis for atrial fibrillation (67%) followed by DVT (18%). While in our study anticoagulation for mechanical valve replacement predominate (58%) followed by anticoagulation for atrial fibrillation (21%). The difference in the predominant age group and the incidence of being mostly in the young age group with anticoagulation for the prosthetic valve is related to the high prevalence of rheumatic heart disease among the young age group in Sudan and hence increase in the rate of prosthetic valve intervention for destructed valves due to R.H.D. During the study period in that research, it is found that the overall result was suboptimal anticoagulation with an INR result (54%) in the therapeutic range while in (46%) was subtherapeutic. This result was similar in range to the suboptimal therapeutic INR result found in our study (54.7%) controlled versus (45.3%) uncontrolled INR. A similar range of results indicates that it is related to facilities other than the presence of well-equipped centers for follow up which is different from our overcrowded small center .it is related to the patient's compliance and education about medication of anticoagulation. In another study conducted in Alberta hospital in Canada about the adequacy of anticoagulation in patients with A.F, Of (375) patients taking warfarin coming to the hospital and having an INR documented in the clinic,( 167) patients (44.5%) were subtherapeutic, (137) patients (36.5%) were therapeutically controlled, and (71) patients (18.9%) were supra therapeutic [10]. In our study of (300) patients taking warfarin, the INR results reveal (that 151) patients (50.3%) were therapeutically controlled, and (92) patients (30.7%) were sub-therapeutic and (57) patients (19%) were supra therapeutic. In a study conducted in Africa in Tanzania, about the adequacy of anticoagulation among patients with MVR, it. is found that only (35.5%) of the measurements were within the recommended therapeutic (normal) range, (33.4%) above therapeutic, and (31.1%) below it [11]. Our study shows a much better percentage in patients with MVR (65.5%) controlled versus (34.5%) uncontrolled. table (3.4). In our study( 65) patients from(300) patients develop complication,(44) patients(14.7%) develop minor bleeding ,while (20) patients(6.7%) develop major bleeding and in one patient(0.3%) thromboembolic event was encountered. In another study conducted in South Africa, It is found that in studying (309) patients there were( 50 ) episodes of complications encountered following anticoagulation after MVR(16.2%), (38) bleeding events with (30) patients(9.7%) develop minor bleeding, and,( 8) patients (2.6%) develop a major bleeding complication. there were also (12) patients(3.1%) who get a thromboembolic complication[13]. In a meta-analysis study of (45) studies conducted in the U.S about hemorrhagic and thromboembolic complications in patients on long term anticoagulation control, it is found that(23) reported both hemorrhages and thromboembolic; (14) that reported hemorrhages only; and( 8) thromboembolic only) involving a median of 208 patients. Of these studies, (64%) were conducted at community practices; the remainder were at anticoagulation clinics. About (69%) of the studies were classed as having moderate or high quality. Overall,( 44%) of hemorrhages occurred when INRs were above the therapeutic range, and (48%) of thromboembolic took place when below it [14]. The involvement of patients in the management of anticoagulation therapy was studied in some trials. It was found that patient awareness of the INR values correlated with improved accuracy of anticoagulation control[15]. Our study confirms these data. The patients who had received satisfactory education on anticoagulation had the highest quality of anticoagulation and were less prone to complications. Our study has some limitations including a limited sample size, we conducted the study at a single center, thereby potentially limiting the ability to generalize our data, limiting our ability to explore additional factors that may have contributed to sub-optimal INR such as acute co-morbidities and variability in dietary vitamin K intake One of the most important findings of our study was the significance of the patient’s knowledge about anticoagulation. Patient education is generally performed by the medical staff and includes the purposes of anticoagulation, risk of complications, and information about INR values. The poor quality of such education was the most significant risk factor for complications and the ineffectiveness of anticoagulation. Moreover, insufficient education was more devastating than the total lack of education. Low-quality education resulted in the highest rate of bleeding complications and over coagulation. Poor education on anticoagulation was the most reliable risk factor for adverse outcomes in our study. P-value (0.001). Limitations of the study were that it was not an intervention trial and that the education process was not standardized.
The study of the adequacy of anticoagulation shows suboptimal control in (45.3%) of patients on patients attending INR clinics, however, the adequacy varies with age group with elderly patients poorly anticoagulated. The main indication of anticoagulation is MVR which shows a higher percentage of adequately controlled INR (65.5%) Fallowed by anticoagulation due to AF and cardiomyopathy which on the other hand shows a higher percentage of sub-therapeutic control of INR (65.2%) and (62.8%) respectively. The adequacy of anticoagulation is directly proportionate to the educational aspect about the interaction of medication and diet to warfarin therapy with a higher percentage under control in patients who were not educated (61.7%).versus control rate (38.3%). The complication of warfarin use in form of major and minor bleeding was encountered in a higher percentage of patients with uncontrolled high INR (55%) and (56.8%) respectively .with one patient who develop thromboembolic who was under control. Finally, the overall research conclude that the adequacy of anticoagulation was suboptimal with (54.6%) adequately controlled versus (45.3%) uncontrolled. In conclusion, the INR range of anticoagulation at the referral clinic mostly falls in the “under anticoagulated range”. Areas to be considered are patient attendance, staffing and at the same time increasing the efficiency of services. Improvement should be directed not only toward attaining better patient attendance at the clinic but also to educate patients on the importance of adequate control.
There was no specific grant for this research from any funding agencies.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
